Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
???displayArticle.abstract???
The body of scientific literature linking Wnts and Wnt-associated proteins to human disease processes continues to grow in parallel with new discoveries from basic science laboratories that further characterize the elaborate cellular events following the binding of Wnts to their receptors. While Wnt-mediated signaling has long been known to play a major role in human carcinogenesis, accumulating evidence indicates that Wnts are also important mediators of inflammation and recovery from injury. The binding of secreted Wnt ligands to their receptors offers an attractive and accessible target for therapeutic regulation of these signaling pathways. Several promising preliminary studies have already addressed potential avenues for the manipulation of Wnt signaling in disease processes. This review will focus on disease processes involving the regulation of Wnt signaling at the level of Wnt binding to its target receptors. Wnt proteins, Wnt receptors, and secreted Wnt inhibitors are attractive as potential therapeutic agents and targets due to their extracellular location. In addition, since Wnt signaling results in a diverse array of downstream intracellular events, many of which are not fully understood, the targeting of this pathway at the most upstream site of pathway activation also provides a strategic advantage for therapy. As the list of Wnt-related diseases continues to grow, advances in our understanding of the biochemical and molecular mechanisms underlying Wnt signaling may ultimately translate into innovative ways to treat Wnt-related disease processes in patients.
Alonso,
Stem cells in the skin: waste not, Wnt not.
2003, Pubmed
Alonso,
Stem cells in the skin: waste not, Wnt not.
2003,
Pubmed Bennett,
Regulation of Wnt signaling during adipogenesis.
2002,
Pubmed Bernier,
Pharmacological chaperones: potential treatment for conformational diseases.
2004,
Pubmed Bhanot,
A new member of the frizzled family from Drosophila functions as a Wingless receptor.
1996,
Pubmed Bouillet,
A new mouse member of the Wnt gene family, mWnt-8, is expressed during early embryogenesis and is ectopically induced by retinoic acid.
1996,
Pubmed
,
Xenbase Cappuccio,
Induction of Dickkopf-1, a negative modulator of the Wnt pathway, is required for the development of ischemic neuronal death.
2005,
Pubmed Caricasole,
Induction of Dickkopf-1, a negative modulator of the Wnt pathway, is associated with neuronal degeneration in Alzheimer's brain.
2004,
Pubmed Carr,
Gene-expression profiling in human cutaneous melanoma.
2003,
Pubmed Chen,
SKI activates Wnt/beta-catenin signaling in human melanoma.
2003,
Pubmed Cheyette,
Ryk: another heretical Wnt receptor defies the canon.
2004,
Pubmed Cong,
Wnt signals across the plasma membrane to activate the beta-catenin pathway by forming oligomers containing its receptors, Frizzled and LRP.
2004,
Pubmed Finch,
Purification and molecular cloning of a secreted, Frizzled-related antagonist of Wnt action.
1997,
Pubmed
,
Xenbase Funayama,
Embryonic axis induction by the armadillo repeat domain of beta-catenin: evidence for intracellular signaling.
1995,
Pubmed
,
Xenbase Gregory,
Dkk-1-derived synthetic peptides and lithium chloride for the control and recovery of adult stem cells from bone marrow.
2005,
Pubmed Gregory,
The Wnt signaling inhibitor dickkopf-1 is required for reentry into the cell cycle of human adult stem cells from bone marrow.
2003,
Pubmed Grotewold,
The Wnt antagonist Dickkopf-1 is regulated by Bmp signaling and c-Jun and modulates programmed cell death.
2002,
Pubmed Häusler,
Secreted frizzled-related protein-1 inhibits RANKL-dependent osteoclast formation.
2004,
Pubmed He,
A monoclonal antibody against Wnt-1 induces apoptosis in human cancer cells.
2004,
Pubmed He,
A member of the Frizzled protein family mediating axis induction by Wnt-5A.
1997,
Pubmed
,
Xenbase He,
Blockade of Wnt-1 signaling induces apoptosis in human colorectal cancer cells containing downstream mutations.
2005,
Pubmed He,
Secreted frizzled-related protein 4 is silenced by hypermethylation and induces apoptosis in beta-catenin-deficient human mesothelioma cells.
2005,
Pubmed Hussain,
Wnt impacts growth and differentiation in ex vivo liver development.
2004,
Pubmed Huusko,
Nonsense-mediated decay microarray analysis identifies mutations of EPHB2 in human prostate cancer.
2004,
Pubmed Kanazawa,
Association of the gene encoding wingless-type mammary tumor virus integration-site family member 5B (WNT5B) with type 2 diabetes.
2004,
Pubmed Kaykas,
Mutant Frizzled 4 associated with vitreoretinopathy traps wild-type Frizzled in the endoplasmic reticulum by oligomerization.
2004,
Pubmed Kléber,
Wnt signaling and the regulation of stem cell function.
2004,
Pubmed Kohn,
Wnt and calcium signaling: beta-catenin-independent pathways.
2005,
Pubmed Kremenevskaja,
Wnt-5a has tumor suppressor activity in thyroid carcinoma.
2005,
Pubmed Lee,
Dickkopf-1 antagonizes Wnt signaling independent of beta-catenin in human mesothelioma.
2004,
Pubmed Liang,
Wnt5a inhibits B cell proliferation and functions as a tumor suppressor in hematopoietic tissue.
2003,
Pubmed Loughlin,
Functional variants within the secreted frizzled-related protein 3 gene are associated with hip osteoarthritis in females.
2004,
Pubmed Malbon,
Wnt signaling and heterotrimeric G-proteins: strange bedfellows or a classic romance?
2001,
Pubmed Mao,
LDL-receptor-related protein 6 is a receptor for Dickkopf proteins.
2001,
Pubmed
,
Xenbase Maye,
Multiple mechanisms for Wnt11-mediated repression of the canonical Wnt signaling pathway.
2004,
Pubmed Mazieres,
Wnt2 as a new therapeutic target in malignant pleural mesothelioma.
2005,
Pubmed Mazieres,
Inhibition of Wnt16 in human acute lymphoblastoid leukemia cells containing the t(1;19) translocation induces apoptosis.
2005,
Pubmed McCrea,
A homolog of the armadillo protein in Drosophila (plakoglobin) associated with E-cadherin.
1991,
Pubmed
,
Xenbase McMahon,
Ectopic expression of the proto-oncogene int-1 in Xenopus embryos leads to duplication of the embryonic axis.
1989,
Pubmed
,
Xenbase Merle,
Functional consequences of frizzled-7 receptor overexpression in human hepatocellular carcinoma.
2004,
Pubmed Mikami,
Efficacy of Wnt-1 monoclonal antibody in sarcoma cells.
2005,
Pubmed Moon,
The promise and perils of Wnt signaling through beta-catenin.
2002,
Pubmed
,
Xenbase Moon,
WNT and beta-catenin signalling: diseases and therapies.
2004,
Pubmed Morin,
Wnt signaling in human cancer.
2003,
Pubmed Morizono,
Lentiviral vector retargeting to P-glycoprotein on metastatic melanoma through intravenous injection.
2005,
Pubmed Nagayama,
Therapeutic potential of antibodies against FZD 10, a cell-surface protein, for synovial sarcomas.
2005,
Pubmed Pandur,
Wnt-11 activation of a non-canonical Wnt signalling pathway is required for cardiogenesis.
2002,
Pubmed
,
Xenbase Perantoni,
Renal development: perspectives on a Wnt-dependent process.
2003,
Pubmed Rattner,
A family of secreted proteins contains homology to the cysteine-rich ligand-binding domain of frizzled receptors.
1997,
Pubmed Rhee,
Wnt and frizzled receptors as potential targets for immunotherapy in head and neck squamous cell carcinomas.
2002,
Pubmed Riggleman,
Spatial expression of the Drosophila segment polarity gene armadillo is posttranscriptionally regulated by wingless.
1990,
Pubmed Rijsewijk,
The Drosophila homolog of the mouse mammary oncogene int-1 is identical to the segment polarity gene wingless.
1987,
Pubmed Roth,
Secreted Frizzled-related proteins inhibit motility and promote growth of human malignant glioma cells.
2000,
Pubmed Rubinfeld,
Stabilization of beta-catenin by genetic defects in melanoma cell lines.
1997,
Pubmed Rubinfeld,
Association of the APC gene product with beta-catenin.
1993,
Pubmed Seale,
Adult stem cell specification by Wnt signaling in muscle regeneration.
2003,
Pubmed Sen,
Blockade of Wnt-5A/frizzled 5 signaling inhibits rheumatoid synoviocyte activation.
2001,
Pubmed Shum,
Retinoic acid induces down-regulation of Wnt-3a, apoptosis and diversion of tail bud cells to a neural fate in the mouse embryo.
1999,
Pubmed Su,
Association of the APC tumor suppressor protein with catenins.
1993,
Pubmed Surendran,
Wnt-dependent beta-catenin signaling is activated after unilateral ureteral obstruction, and recombinant secreted frizzled-related protein 4 alters the progression of renal fibrosis.
2005,
Pubmed Surendran,
CNP gene expression is activated by Wnt signaling and correlates with Wnt4 expression during renal injury.
2003,
Pubmed Suzuki,
Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer.
2004,
Pubmed Taketo,
Shutting down Wnt signal-activated cancer.
2004,
Pubmed Tao,
Maternal wnt11 activates the canonical wnt signaling pathway required for axis formation in Xenopus embryos.
2005,
Pubmed
,
Xenbase Terada,
Expression and function of the developmental gene Wnt-4 during experimental acute renal failure in rats.
2003,
Pubmed Terami,
Wnt11 facilitates embryonic stem cell differentiation to Nkx2.5-positive cardiomyocytes.
2004,
Pubmed
,
Xenbase van Gijn,
The wnt-frizzled cascade in cardiovascular disease.
2002,
Pubmed Veeman,
A second canon. Functions and mechanisms of beta-catenin-independent Wnt signaling.
2003,
Pubmed Vincan,
Frizzled-7 receptor ectodomain expression in a colon cancer cell line induces morphological change and attenuates tumor growth.
2005,
Pubmed Weeraratna,
Wnt5a signaling directly affects cell motility and invasion of metastatic melanoma.
2002,
Pubmed Wehrli,
arrow encodes an LDL-receptor-related protein essential for Wingless signalling.
2000,
Pubmed Weidinger,
When Wnts antagonize Wnts.
2003,
Pubmed Willert,
Wnt proteins are lipid-modified and can act as stem cell growth factors.
2003,
Pubmed
,
Xenbase Winn,
Restoration of Wnt-7a expression reverses non-small cell lung cancer cellular transformation through frizzled-9-mediated growth inhibition and promotion of cell differentiation.
2005,
Pubmed Yamamoto,
Shisa promotes head formation through the inhibition of receptor protein maturation for the caudalizing factors, Wnt and FGF.
2005,
Pubmed
,
Xenbase Yang-Snyder,
A frizzled homolog functions in a vertebrate Wnt signaling pathway.
1996,
Pubmed
,
Xenbase You,
Inhibition of Wnt-2-mediated signaling induces programmed cell death in non-small-cell lung cancer cells.
2004,
Pubmed You,
An anti-Wnt-2 monoclonal antibody induces apoptosis in malignant melanoma cells and inhibits tumor growth.
2004,
Pubmed
